| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-06 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.5 | 0.003 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.003 |